Polaryx Therapeutics, Inc. (PLYX)
Nasdaq · Pharmaceutical Preparations · Inc. WY
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Polaryx Therapeutics, Inc.. Most notable: 2026-07-21: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Insider purchaseMstone Partners Healthcare Ltd (director) bought $360k of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | Yang Alex Keun Mo; Mstone Partners Healthcare Ltd | director | P | 88,453 | 4.07 | $360,004 |
| 2026-05-27 | Mstone Partners Healthcare Ltd | director | P | 88,453 | 4.07 | $360,004 |
| 2026-02-18 | Landis G. Michael | director | P | 2,867 | 2.79 | $7,991 |
| 2026-02-18 | Landis G. Michael | director | P | 2,867 | 2.79 | $7,999 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.